VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Showed up in my google news feed

<< Previous

Bullboard Posts

Next >>

Comment by Banderas1209on Jan 31, 2021 10:00am

184 Views

Post# 32430976

RE:RE:RE:RE:RE:RE:RE:Showed up in my google news feed

There is NO competition besides Tomtec

With hospitals only focusing on COVID and most departments closed it s logical that sales are slow

now that more and more Covid patients are having heart problems we will soon see some sales soon

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading